Companies

operates a "Cool Corridor" network of temperature-controlled logistics lanes for healthcare shipments, recently expanding both its air-logistics cool-chain coverage and its North American healthcare footprint.

runs a ranked UK life-sciences IP practice combining patent prosecution with lifecycle and litigation support, referenced in industry guides on global patent renewal-fee structures.

the International Society for Medical Publication Professionals' European meeting serves as a recurring venue where medical-affairs and scientific-publications trends are discussed, with vendors such as Mavens (Komodo Health) active participants in 2026.

runs a dedicated regulatory and reimbursement consulting practice supporting medical device companies through both FDA 510(k) submission and CPT/HCPCS coding strategy.

runs a dedicated sensory and consumer-research practice offering sensory claim validation and reformulation-impact testing, positioned around ingredient-change impact on taste, texture and aroma for repeat-purchase risk.

UK-headquartered, runs an FMCG-focused sensory-science practice combining trained descriptive panels with sensory-AI-driver modeling, and published its first peer-reviewed paper in the Journal of Food Quality and Preference in 2026.

provides market-ready healthcare logistics solutions for European pharmaceutical supply chains, including a 2026 UK partnership with the NHS strengthening pharmaceutical logistics.

built the BFF printer hardware and completed the first in-space bioprinting test with it, selling precision bio-dispensing systems as a merchant manufacturer rather than operating flights itself.

runs engagement-based IP valuations for biotechnology startups, including capital-raise support for companies holding therapeutic and diagnostic patent portfolios.

runs a dedicated HEOR and market-access practice, presenting research at ISPOR 2026 alongside the field's other major players.

HCP-compliant medical-affairs platform — Unified field & brand engagement.

contributes to the field's methodological debate, including work on structuring payer-tradeoff analysis ahead of market-access decisions.

provides fee and renewal-management services designed to eliminate the operational overhead of tracking annuity deadlines across a global patent portfolio.

advises chemical manufacturers and downstream users — refillers, formulators, article producers — on chemical-safety compliance across the multi-jurisdictional REACH supply chain.

a Hangzhou-headquartered consultancy advising Chinese chemical manufacturers, including bio-based chemical producers, on REACH registration and the broader landscape of global chemical-compliance obligations facing exporters.

a market-access advisory firm focused specifically on commercial and private-payer coverage policy and prior-authorization navigation for medical devices.

the world's largest FDA cosmetic-registration company with 30,000+ customers, offering comprehensive MoCRA compliance solutions following the most significant changes to US cosmetics regulation in decades.

GMP/GDP specialist audits — Pharma, biotech and cosmetics scope.

a globally recognized research organization dedicated to improving healthcare decisions through evidence generation, with HEOR's role expanding earlier into trial design and value strategy even as resources remain constrained.

maintains the proprietary Spectrum Method and physical intensity references, including a 7.5-point Universal Aromatic Intensity Scale anchor recalibrated in 2026, and runs a long-running Descriptive Panel Leadership training course for panel leaders across the industry.

in 2026 launched a comprehensive agentic-AI suite for medical-affairs operations and a purpose-built medical-information platform (MedInfosys), alongside its established Tika MSL CRM product.

a French regulatory specialist preparing Novel Food dossiers under EU regulation, guiding clients through the procedures required to secure EU market access for innovative food ingredients.

runs a specialty-pharmacy Bridge Program managing high-volume sample and patient-support operations day to day.

the dominant unified platform spanning medical-inquiry management, publications planning and MSL engagement in a single suite, with a dedicated Veeva MedComms product for medical-information case handling.

unifies regulatory registrations, submissions and health-authority correspondence on one cloud platform with a shared data model across regulatory business functions.

its 3E Insight platform uses embedded agentic AI to monitor REACH, TSCA, CLP, GHS, OSHA HazCom and 3,200+ regulatory lists across 150+ countries, screening changes against a client's specific product portfolio rather than delivering a generic regulatory feed.

based in the Netherlands, advises life-sciences clients on policy shaping and commercial strategy across European reimbursement systems, addressing the persistent gap between what a device can offer and what patients actually receive under national coverage decisions.

a France-based consultancy guiding IND and Clinical Trial Application (CTA) submissions under the EU Clinical Trials Regulation, filing 20+ new US INDs and 20+ CTAs per year for clients entering both the EU and US markets.

AI-driven IP portfolio-management platforms optimize portfolio value across 195 countries, while pharma-specific patent-expiration tracking tools serve business-development teams assessing competitor exclusivity timelines.

the DTC pioneer whose opt-in DNA database passed 15 million profiles and funded a drug-discovery arm; after a voluntary Chapter 11 process in March 2025 and a court-supervised sale, it continues ordinary operations under restructured ownership,…

a US filament brand compounding virgin Ingeo resin into functional grades — Tough Pro PLA+ delivers 8.8x the impact toughness of standard PLA+ in drop testing with no annealing required, and its heat resistance can be pushed to rival ABS through post-print annealing (at the cost of 1-2% shrinkage);…

founded in 1974 and based in Bethlehem, PA, ABEC was first to market in 2016 with large-scale single-use systems; its Custom Single Run (CSR) bioreactors were selected for Eli Lilly's next-generation single-use facility in Limerick,…

makes Accoya acetylated solid wood and Tricoya acetylated wood elements by reacting timber with acetic anhydride, permanently acetylating its hydroxyl groups; reported record global Accoya sales of 77,237 m³ for the year ended 31 March 2026 (+21% year-on-year, North America +60%),…

End-to-end gene-synthesis compliance platform — Columbia University spinout; real-time screening, sub-3-second turnaround; customers incl. Ansa Biotechnologies.

Akoya's PhenoCycler-Fusion is the spatial-proteomics leader, detecting 100-plus protein biomarkers per section at 0.25 µm/pixel with cyclic immunofluorescence plus in-situ-hybridisation RNA modules;…

early US entrants (AlgenAir) raised through equity crowdfunding platforms before moving to direct e-commerce sale.

AlGreen originated from a Hong Kong University of Science and Technology biotechnology course project before incorporating.

a Ginkgo Bioworks spinout whose RE-Cover platform uses engineered proteins to bind rare earth elements — neodymium, praseodymium, yttrium — from coal ash, mine tailings and mine-impacted water in modular, site-deployable systems,…

the leading RNAi company; AMVUTTRA (vutrisiran) is approved for both forms of ATTR amyloidosis, with the first quarter of 2026 marking one year since the U.S. ATTR-CM launch — a significant commercial milestone;…

Corpus Christi Polymers (PTA-PET JV) — Co-owner of the Texas integrated PTA-PET complex; licensed bio-MEG PRODESA technology.

its digital therapy intervention for childhood autism spectrum disorder has entered 14 hospitals and 3 rehabilitation institutions in Hainan province, achieving a 94% effective intervention rate under a Hainan government subsidy program (approximately 3,000 yuan per patient),…

Natural indigo dye, GOTS-certified natural dyes — Exports to Europe, USA, Japan and Southeast Asia; industrial-grade purity.

its cycora regenerated polyester, made by molecular regeneration of end-of-life textiles, has been validated as virgin-grade by the European Center for Innovative Textiles (CETI); Ambercycle secured an USD 81 million, three-year contract with Inditex (Zara) in 2024, an Hyosung TNC partnership,…

a small, growing hemp building-materials company (2 employees, up 33% year-on-year) offering hempcrete installation services, hemp hurd and lime binder supply, and design consultation; licenses and distributes the French Baumer Ereasy spray-application technology to apply hempcrete directly onto wall cavities on site,…

the Emeryville synthetic-biology firm built a Lab-to-Market platform turning plant sugars into molecules like squalane and ambroxide, amassing about 700 patents and 16 products before a 1.15-billion-dollar debt crisis drove a 2023 Chapter 11 reorganization and a pivot to B2B ingredient supply.

Darling's Diamond Green Diesel JV with Valero sold 272.4 million gallons of renewable fuel in Q1 2026 on group net sales of US$1.38 billion, sourcing waste fats and used cooking oil into renewable diesel and SAF;…

founded by Polish genealogists, offers escorted heritage tours across Belarus, Germany, Hungary, Romania, Slovenia, Czechia, Latvia, Lithuania, Poland, Slovakia, Ukraine and Russia, with a local genealogist accompanying each trip to local record holdings.

its INSPECTA platform is a unified, modular software suite for pharmaceutical vision inspection that integrates with primary and secondary packaging machinery, providing presence/absence and foreign-object detection, colour control against references, in-line leak detection for aerosols and blister filling control,…

the Alcolyzer Beer analyzing system, EasyDens digital gravity/alcohol tester and Alex 301/501 alcohol and extract analyzer form a dedicated product line for brewery alcohol and density measurement, a leading producer of analytical testing equipment for commercial breweries.

its AquAdvantage GE salmon — the first genetically engineered food animal, FDA-approved in 2015 — was rejected by 80+ retailers (Walmart, Costco, Sodexo, Aramark) and AquaBounty shut its last farm (Bay Fortune, PEI) in December 2024; Q1 2026 net loss $1.2M on $441k cash,…

its BioElectrochemical Treatment Technology (BETT) has been sold commercially for roughly a decade, treating food-and-beverage and confectionery wastewater onsite; case studies report up to 95% organics removal, 97.6% less sludge than an anaerobic digester,…

the STAC online early-warning system and SOMQUALITY-NTU infrared-scattering turbidity sensor (0-4,000 NTU range) address both continuous early-detection alerting and standard turbidity measurement for municipal and industrial water operators.

the ARK Genomic Revolution ETF (ARKG) is an actively managed thematic fund concentrated in genomics and biotechnology companies, also offered through a European UCITS structure for cross-border distribution.

launched bio-based Ethyl Acrylate produced entirely from bioethanol at its Carling acrylic monomer facility in October 2024, achieving 40% bio carbon content (BCC) and up to 30% reduction in product carbon footprint (PCF) per IPCC 2021 GWP100 assumptions;…

AP-SA02, an IV phage cocktail dosed alongside standard antibiotics for complicated S. aureus bacteremia, read out positive Phase 2a data in May 2025, received FDA Qualified Infectious Disease Product designation,…

a global infrastructure and sustainability consultancy spanning 150+ disciplines, publishing work specifically on how cities can stay cool and biodiverse as they grow denser, applying biomimicry principles within its broader urban design and sustainability practice.

launched Chrysalis transposase in June 2026, a proprietary genome-integration tool engineered from butterfly species delivering stable expression across 60+ generations and clonal titers above 12 g/L,…

a global leader in endotoxin and (1→3)-β-D-glucan detection for over 50 years, ACC pioneered modern LAL testing methodology and is hosting an industry forum on expanding rCR adoption in Europe, reflecting its active role in the animal-free transition.

backs a broad derivative portfolio including DemeRx's noribogaine, an ibogaine metabolite cleared by the FDA for first-in-human testing as a non-psychoactive, lower-cardiotoxicity alternative to ibogaine,…

the world's largest land-based salmon farm in Homestead, FL (founded 2010), Phase-1 capacity 7,500–8,500 t/yr; Q1 2026 harvest 1,504 t HOG (+27% QoQ) at USD 9.32/kg — but the company entered a restructuring agreement in May 2026 after a $10M bridge loan (12% interest,…